Issues from Bench to Market with Advanced Therapeutics

Mini Symposium

Date/Time: Tuesday, July 23, 2019 - 4:00 PM to 6:00 PM
Log in to Add to My Schedule


This session will discuss the current trends and challenges in the clinical translation of Drug Delivery Technologies as well as the potential pathways for translational development and commercialization. Key issues will be covered, including biological challenges, large-scale manufacturing, biocompatibility and safety, intellectual property (IP), government regulations, and overall cost-effectiveness in comparison to current therapies. Collaborations and communications between the stakeholders in this field, namely academia, Clinicians, industry and regulatory authorities, must be strengthened in order for the promise of translational research to be delivered as better therapies to patients. This is the idea of the present minisymposium where regulators (FDA), industry (including AstraZeneca, Alnylam), academia and well-known clinicians will discuss on the current challenges and opportunities to push forward the translation from bench to bedside with drug delivery technologies